BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Prieto-Granada C, Rodriguez-Waitkus P. Basal cell carcinoma: Epidemiology, clinical and histologic features, and basic science overview. Curr Probl Cancer 2015;39:198-205. [PMID: 26239203 DOI: 10.1016/j.currproblcancer.2015.07.004] [Cited by in Crossref: 15] [Cited by in F6Publishing: 11] [Article Influence: 2.1] [Reference Citation Analysis]
Number Citing Articles
1 Cohen PR. Red Dot Basal Cell Carcinoma: Report of Cases and Review of This Unique Presentation of Basal Cell Carcinoma. Cureus 2017;9:e1110. [PMID: 28465868 DOI: 10.7759/cureus.1110] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 0.4] [Reference Citation Analysis]
2 Mahajan S, Kalaivani M, Sethuraman G, Khaitan BK, Verma KK, Gupta S. A retrospective comparative study of outcome with surgical excision and repair versus nonsurgical and ablative treatments for basal cell carcinoma. Indian J Dermatol Venereol Leprol 2021;87:348-56. [PMID: 33666033 DOI: 10.25259/IJDVL_170_19] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
3 Williams HC, Bath-hextall F, Ozolins M, Armstrong SJ, Colver GB, Perkins W, Miller PS. Surgery Versus 5% Imiquimod for Nodular and Superficial Basal Cell Carcinoma: 5-Year Results of the SINS Randomized Controlled Trial. Journal of Investigative Dermatology 2017;137:614-9. [DOI: 10.1016/j.jid.2016.10.019] [Cited by in Crossref: 72] [Cited by in F6Publishing: 63] [Article Influence: 14.4] [Reference Citation Analysis]
4 Ahmadi-Beni R, Vand-Rajabpour F, Ahmadifard M, Daneshpazhooh M, Noormohammadpour P, Rahmati J, Hesari KK, Yaseri M, Tabrizi M. Decreased Sox2 Messenger RNA Expression in Basal Cell Carcinoma. Indian J Dermatol 2020;65:178-82. [PMID: 32565556 DOI: 10.4103/ijd.IJD_387_18] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
5 Kubanov AA, Saytburkhanov RR, Plakhova XI, Kondrakhina IN. Non-surgical treatments for basal cell skin cancer. Vestnik dermatologii i venerologii 2021;97:20-32. [DOI: 10.25208/vdv1294] [Reference Citation Analysis]
6 Gaspari V, Patrizi A, Venturi M, Misciali C, Fanti PA. The epidemic spreading of basal cell carcinoma: incidence trend, demographic features, characteristics and risk factors in a retrospective study of 8557 lesions in Bologna. A 25-year analysis in a Dermatology referral center. G Ital Dermatol Venereol 2020;155:24-30. [PMID: 28421727 DOI: 10.23736/S0392-0488.17.05617-6] [Reference Citation Analysis]
7 Schmitt J, Haufe E, Trautmann F, Schulze H, Elsner P, Drexler H, Bauer A, Letzel S, John SM, Fartasch M, Brüning T, Seidler A, Dugas-breit S, Gina M, Weistenhöfer W, Bachmann K, Bruhn I, Lang BM, Bonness S, Allam JP, Grobe W, Stange T, Westerhausen S, Knuschke P, Wittlich M, Diepgen TL. Occupational UV-Exposure is a Major Risk Factor for Basal Cell Carcinoma: Results of the Population-Based Case-Control Study FB-181. Journal of Occupational & Environmental Medicine 2018;60:36-43. [DOI: 10.1097/jom.0000000000001217] [Cited by in Crossref: 34] [Cited by in F6Publishing: 9] [Article Influence: 8.5] [Reference Citation Analysis]
8 Cohen BJ, Cohen ES, Cohen PR. Basal Cell Carcinoma: A Patient and Physician's Experience. Dermatol Ther (Heidelb) 2018;8:329-37. [PMID: 29860652 DOI: 10.1007/s13555-018-0245-2] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
9 Sabri A, Ogilvie J, McKenna J, Segal J, Scurr D, Marlow M. Intradermal Delivery of an Immunomodulator for Basal Cell Carcinoma; Expanding the Mechanistic Insight into Solid Microneedle-Enhanced Delivery of Hydrophobic Molecules. Mol Pharm 2020;17:2925-37. [PMID: 32510228 DOI: 10.1021/acs.molpharmaceut.0c00347] [Cited by in Crossref: 10] [Cited by in F6Publishing: 8] [Article Influence: 5.0] [Reference Citation Analysis]
10 Caruana M, Morand M, Belisle A, Nantel-Battista M. Basal cell carcinoma stroma as a mimicker of lymphatic invasion: A case report. SAGE Open Med Case Rep 2020;8:2050313X20919602. [PMID: 32477557 DOI: 10.1177/2050313X20919602] [Reference Citation Analysis]
11 Cameron MC, Lee E, Hibler BP, Barker CA, Mori S, Cordova M, Nehal KS, Rossi AM. Basal cell carcinoma: Epidemiology; pathophysiology; clinical and histological subtypes; and disease associations. J Am Acad Dermatol 2019;80:303-17. [PMID: 29782900 DOI: 10.1016/j.jaad.2018.03.060] [Cited by in Crossref: 87] [Cited by in F6Publishing: 83] [Article Influence: 21.8] [Reference Citation Analysis]
12 TaslÎca R, Georgescu CV, PĂtraŞcu V. Adenoid Cystic Basal Cell Carcinoma Arising in Rhinophyma. Curr Health Sci J 2020;46:309-14. [PMID: 33304635 DOI: 10.12865/CHSJ.46.03.15] [Reference Citation Analysis]